Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2010-06-23 Share Issue/Capital Cha…
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Appendix 3B 9 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose of the issue, and details about quotation on the ASX. It is a formal announcement related to a new share issue and application for quotation of additional securities. The document does not contain financial statements or management discussion but is a regulatory announcement about capital raising and securities issuance. This fits the definition of a 'Share Issue/Capital Change' filing, which covers announcements regarding new share issues or capital changes.
2010-06-23 English
Clarification to Misleading Information in the Market 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter from the company clarifying misleading information about the results of a General Meeting held on 22 June 2010. It discusses voting outcomes and proxy votes related to resolutions at the meeting. The document references the Results of Meeting lodged with ASX on the same date but does not itself provide detailed voting results or financial data. The content is focused on clarifying shareholder voting results and correcting market misinformation rather than presenting the actual voting results or detailed meeting materials. The document length is short (3795 characters) and serves as a clarification announcement rather than the official voting results or meeting materials. Therefore, it fits best as a Declaration of Voting Results & Voting Rights Announcement (DVA).
2010-06-23 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules (2.7, 3.10.3, 3.10.4, 3.10.5). It details the issuance of new securities, specifically unlisted options over ordinary shares, including number of securities, terms, issue price, purpose, and escrow details. It also includes a quotation agreement with ASX and detailed schedules of restricted securities and convertible notes. The document is a formal announcement of a new securities issue and application for quotation, consistent with regulatory filings for capital raising and securities issuance. It does not contain financial statements, earnings data, or management discussion, nor is it a report or presentation. It is not a report publication announcement since it contains substantive information about the securities issued. Therefore, the document fits the category of Capital/Financing Update (CAP).
2010-06-22 English
Chairman`s Address to Shareholders 3 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is a Chairman's address at a general meeting of members, discussing shareholder approval for prior share and option issues under ASX Listing Rules and the Corporations Act. It focuses on ratification of share issuances and capital raising activities, with no detailed financial statements or comprehensive financial performance data. The document is relatively short (3717 characters) and is clearly a meeting speech or presentation related to capital raising and shareholder approval. This fits best with a Capital/Financing Update (CAP) category, as it deals with share issuance approvals and financing arrangements rather than a full report or regulatory filing.
2010-06-21 English
Results of Meeting 2 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a communication dated 22 June 2010 addressed to the ASX Company Announcements Office. It reports the results of a General Meeting of CBio Limited, specifically detailing the voting outcomes on several resolutions. The text includes vote counts for each resolution and confirms that all resolutions were passed unanimously. There is no detailed financial data, management discussion, or full report content. The document is short (2524 characters) and serves as an official announcement of voting results rather than the meeting materials or a full report. According to the filing definitions, this matches the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'.
2010-06-21 English
Appendix 3B 10 pages ?Kb
Capital/Financing Update Classification · 95% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of convertible notes, terms of the securities, number and class of securities, and application for quotation on the ASX. It includes sections on the principal terms of the securities, issue price, purpose of the issue, and quotation agreement. The document is a formal announcement related to the issuance of new securities and their listing on the stock exchange. It does not contain financial statements, management discussion, or audit information. It is not a full financial report but rather a regulatory announcement about a capital raising event and securities issuance. This fits the definition of a Capital/Financing Update (CAP). The document length is over 14,000 characters, indicating it is a full announcement rather than a brief notice or report publication announcement.
2010-06-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.